Using this cohort of Japanese patients with HNSCC as post hoc analysis, we newly explored if UGT2B17-deletion modify effects of smoking on TP53-mutations, in combination with p16 (+). The gene discussed is UGT2B17; the disease is head and neck squamous cell carcinoma.